S&P 500   4,026.94 (+1.40%)
DOW   32,712.31 (+0.98%)
QQQ   312.43 (+1.73%)
AAPL   160.49 (+1.80%)
MSFT   279.74 (+1.64%)
META   205.29 (+2.30%)
GOOGL   101.32 (+0.29%)
AMZN   100.20 (+3.04%)
TSLA   192.51 (+1.75%)
NVDA   269.39 (+2.00%)
NIO   9.92 (+7.83%)
BABA   101.13 (+2.77%)
AMD   96.01 (+1.53%)
T   19.01 (+1.55%)
F   12.00 (+3.45%)
MU   63.80 (+7.62%)
CGC   1.84 (+1.66%)
GE   94.16 (+1.10%)
DIS   96.65 (+1.93%)
AMC   4.96 (-3.69%)
PFE   40.16 (+0.43%)
PYPL   74.07 (+1.88%)
NFLX   331.56 (+2.49%)
S&P 500   4,026.94 (+1.40%)
DOW   32,712.31 (+0.98%)
QQQ   312.43 (+1.73%)
AAPL   160.49 (+1.80%)
MSFT   279.74 (+1.64%)
META   205.29 (+2.30%)
GOOGL   101.32 (+0.29%)
AMZN   100.20 (+3.04%)
TSLA   192.51 (+1.75%)
NVDA   269.39 (+2.00%)
NIO   9.92 (+7.83%)
BABA   101.13 (+2.77%)
AMD   96.01 (+1.53%)
T   19.01 (+1.55%)
F   12.00 (+3.45%)
MU   63.80 (+7.62%)
CGC   1.84 (+1.66%)
GE   94.16 (+1.10%)
DIS   96.65 (+1.93%)
AMC   4.96 (-3.69%)
PFE   40.16 (+0.43%)
PYPL   74.07 (+1.88%)
NFLX   331.56 (+2.49%)
S&P 500   4,026.94 (+1.40%)
DOW   32,712.31 (+0.98%)
QQQ   312.43 (+1.73%)
AAPL   160.49 (+1.80%)
MSFT   279.74 (+1.64%)
META   205.29 (+2.30%)
GOOGL   101.32 (+0.29%)
AMZN   100.20 (+3.04%)
TSLA   192.51 (+1.75%)
NVDA   269.39 (+2.00%)
NIO   9.92 (+7.83%)
BABA   101.13 (+2.77%)
AMD   96.01 (+1.53%)
T   19.01 (+1.55%)
F   12.00 (+3.45%)
MU   63.80 (+7.62%)
CGC   1.84 (+1.66%)
GE   94.16 (+1.10%)
DIS   96.65 (+1.93%)
AMC   4.96 (-3.69%)
PFE   40.16 (+0.43%)
PYPL   74.07 (+1.88%)
NFLX   331.56 (+2.49%)
S&P 500   4,026.94 (+1.40%)
DOW   32,712.31 (+0.98%)
QQQ   312.43 (+1.73%)
AAPL   160.49 (+1.80%)
MSFT   279.74 (+1.64%)
META   205.29 (+2.30%)
GOOGL   101.32 (+0.29%)
AMZN   100.20 (+3.04%)
TSLA   192.51 (+1.75%)
NVDA   269.39 (+2.00%)
NIO   9.92 (+7.83%)
BABA   101.13 (+2.77%)
AMD   96.01 (+1.53%)
T   19.01 (+1.55%)
F   12.00 (+3.45%)
MU   63.80 (+7.62%)
CGC   1.84 (+1.66%)
GE   94.16 (+1.10%)
DIS   96.65 (+1.93%)
AMC   4.96 (-3.69%)
PFE   40.16 (+0.43%)
PYPL   74.07 (+1.88%)
NFLX   331.56 (+2.49%)
OTCMKTS:GNGBY

Getinge AB (publ) - GNGBY Stock Forecast, Price & News

$23.14
-0.25 (-1.07%)
(As of 03/28/2023 12:00 AM ET)
Add
Compare
Today's Range
$23.02
$23.17
50-Day Range
$20.26
$24.84
52-Week Range
$15.87
$41.54
Volume
11,133 shs
Average Volume
7,578 shs
Market Capitalization
$6.30 billion
P/E Ratio
25.71
Dividend Yield
1.30%
Price Target
N/A

GNGBY stock logo

About Getinge AB (publ) (OTCMKTS:GNGBY) Stock

Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. It offers products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. The firm operates through the following segments: Acute Care Therapies, Life Science and Surgical Workflows. The Acute Care Therapies segment offers solutions for life support in acute health conditions. The Life Science segment offers a comprehensive range of equipment, technical expertise and consultation to prevent contamination in biopharmaceutical production, biomedical research, medical device manufacturing and laboratory applications. The Surgical Workflows segment offers products and services for efficient disinfection and sterilization of instruments used in operations, operating tables and other high-quality hardware for operating rooms and advanced IT systems for efficient and secure hospital workflows. The company was founded by Olander Larsson in 1904 and is headquartered in Gothenburg, Sweden.

Receive GNGBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Getinge AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

GNGBY Stock News Headlines

Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
GNGBY Getinge AB (publ)
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
Getinge AB ADR
Getinge AB reports Q2 results
Getinge grows with social funding
See More Headlines
Receive GNGBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Getinge AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

GNGBY Company Calendar

Last Earnings
2/01/2023
Today
3/29/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:GNGBY
CIK
N/A
Employees
10,700
Year Founded
N/A

Profitability

Net Income
$246.86 million
Pretax Margin
12.27%

Debt

Sales & Book Value

Annual Sales
$2.81 billion
Cash Flow
$1.81 per share
Book Value
$11.08 per share

Miscellaneous

Free Float
N/A
Market Cap
$6.30 billion
Optionable
Not Optionable
Beta
1.26

Key Executives

  • Mattias Sven Perjos
    President, Chief Executive Officer & Director
  • Lars Sandström
    Chief Financial Officer
  • Anna Romberg
    Executive VP-Legal, Compliance & Governance
  • Carsten Blecker
    Chief Commercial Officer
  • Jens Viebke
    President-Acute Care Therapies Business













GNGBY Stock - Frequently Asked Questions

Should I buy or sell Getinge AB (publ) stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Getinge AB (publ) in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" GNGBY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GNGBY, but not buy additional shares or sell existing shares.
View GNGBY analyst ratings
or view top-rated stocks.

How have GNGBY shares performed in 2023?

Getinge AB (publ)'s stock was trading at $20.62 at the beginning of the year. Since then, GNGBY stock has increased by 12.2% and is now trading at $23.14.
View the best growth stocks for 2023 here
.

Are investors shorting Getinge AB (publ)?

Getinge AB (publ) saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 100 shares, a drop of 96.6% from the February 28th total of 2,900 shares. Based on an average trading volume of 15,700 shares, the days-to-cover ratio is currently 0.0 days.
View Getinge AB (publ)'s Short Interest
.

How were Getinge AB (publ)'s earnings last quarter?

Getinge AB (publ) (OTCMKTS:GNGBY) issued its quarterly earnings data on Wednesday, February, 1st. The company reported $0.31 earnings per share for the quarter. The company earned $793.05 million during the quarter. Getinge AB (publ) had a trailing twelve-month return on equity of 10.07% and a net margin of 8.83%.

How often does Getinge AB (publ) pay dividends? What is the dividend yield for Getinge AB (publ)?

Getinge AB (publ) declared a dividend on Wednesday, April 20th. Shareholders of record on Thursday, April 28th will be given a dividend of $0.3116 per share on Wednesday, May 18th. This represents a dividend yield of 0.85%. The ex-dividend date of this dividend is Wednesday, April 27th.
Read our dividend analysis for GNGBY
.

Is Getinge AB (publ) a good dividend stock?

Getinge AB (publ) (OTCMKTS:GNGBY) pays an annual dividend of $0.30 per share and currently has a dividend yield of 1.27%. The dividend payout ratio is 33.33%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for GNGBY.

What is Getinge AB (publ)'s stock symbol?

Getinge AB (publ) trades on the OTCMKTS under the ticker symbol "GNGBY."

How do I buy shares of Getinge AB (publ)?

Shares of GNGBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Getinge AB (publ)'s stock price today?

One share of GNGBY stock can currently be purchased for approximately $23.14.

How much money does Getinge AB (publ) make?

Getinge AB (publ) (OTCMKTS:GNGBY) has a market capitalization of $6.30 billion and generates $2.81 billion in revenue each year. The company earns $246.86 million in net income (profit) each year or $0.90 on an earnings per share basis.

How many employees does Getinge AB (publ) have?

The company employs 10,700 workers across the globe.

How can I contact Getinge AB (publ)?

Getinge AB (publ)'s mailing address is LINDHOLMSPIREN 7A, GOTHENBURG V7, 41756. The official website for the company is www.getinge.com. The company can be reached via phone at (610) 335-0000, via email at lars.mattsson@getinge.com, or via fax at 46-1-033-556-40.

This page (OTCMKTS:GNGBY) was last updated on 3/29/2023 by MarketBeat.com Staff